499 companies

Concord Biotech

Market Cap: ₹160.3b

A biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally.

CONCORDBIO

₹1,532.10

7D

0.4%

1Y

5.0%

GSK

Market Cap: UK£58.0b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

GSK

UK£14.29

7D

4.8%

1Y

-19.7%

Genus

Market Cap: UK£1.4b

Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.

GNS

UK£19.98

7D

-3.2%

1Y

9.2%

Genomma Lab Internacional. de

Market Cap: Mex$20.5b

Provides pharmaceutical and personal care products primarily in Mexico and internationally.

LAB B

Mex$21.01

7D

-1.6%

1Y

23.2%

Qiagen

Market Cap: US$9.2b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

QGEN

US$42.32

7D

0.2%

1Y

-4.7%

Société de Therapeutique Marocaine

Market Cap: د.م10.1b

A pharmaceutical company, engages in the manufacturing and sale of medicines in Morocco.

SOT

د.م1,444.00

7D

-1.1%

1Y

45.7%

Hypera

Market Cap: R$15.0b

Operates as a pharmaceutical company in Brazil.

HYPE3

R$23.72

7D

-3.9%

1Y

-21.2%

Shenzhen Kangtai Biological Products

Market Cap: CN¥15.6b

Shenzhen Kangtai Biological Products Co., Ltd.

300601

CN¥13.99

7D

-0.4%

1Y

-26.1%

Jiuzhitang

Market Cap: CN¥7.5b

Provides traditional Chinese, chemical, biological, and health medicine products in China.

000989

CN¥8.84

7D

-3.4%

1Y

15.1%

Sunflower Pharmaceutical GroupLtd

Market Cap: CN¥9.3b

Engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally.

002737

CN¥15.92

7D

-1.1%

1Y

-44.6%

Sino Biopharmaceutical

Market Cap: HK$75.3b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

1177

HK$4.21

7D

7.9%

1Y

43.7%

China Resources Boya Bio-pharmaceutical GroupLtd

Market Cap: CN¥13.5b

Engages in the blood product businesses in China.

300294

CN¥26.72

7D

-0.04%

1Y

-18.1%

Daiichi Sankyo Company

Market Cap: JP¥7.0t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

4568

JP¥3,753.00

7D

11.7%

1Y

-30.2%

Jubilant Pharmova

Market Cap: ₹169.2b

Operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally.

530019

₹1,068.65

7D

18.0%

1Y

48.9%

Chugai Pharmaceutical

Market Cap: JP¥12.4t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

4519

JP¥7,516.00

7D

0.01%

1Y

57.0%

Bachem Holding

Market Cap: CHF 3.9b

Provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.

BANB

CHF 49.50

7D

-6.5%

1Y

-42.9%

Shandong Xinhua Pharmaceutical

Market Cap: HK$9.4b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

719

HK$5.91

7D

3.7%

1Y

5.5%

Yifan Pharmaceutical

Market Cap: CN¥15.2b

Engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally.

002019

CN¥12.47

7D

3.0%

1Y

-7.4%

Tianjin Chase Sun PharmaceuticalLtd

Market Cap: CN¥11.1b

Engages in the research and development, production, and sale of various pharmaceutical products in China and internationally.

300026

CN¥3.71

7D

8.8%

1Y

2.2%

Shanghai Fosun Pharmaceutical (Group)

Market Cap: CN¥57.6b

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

600196

CN¥23.95

7D

0.8%

1Y

3.2%

Towa Pharmaceutical

Market Cap: JP¥145.1b

Researches, develops, produces, and sells ethical drugs, active pharmaceutical ingredients, and intermediates in Japan.

4553

JP¥2,947.00

7D

20.0%

1Y

4.6%

Alembic Pharmaceuticals

Market Cap: ₹190.9b

Develops, manufactures, and markets pharmaceutical products in India and internationally.

APLLTD

₹971.20

7D

6.2%

1Y

1.1%

Agilent Technologies

Market Cap: US$31.1b

Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.

A

US$109.68

7D

-2.4%

1Y

-27.1%

Eli Lilly

Market Cap: US$670.6b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

LLY

US$724.95

7D

1.3%

1Y

-9.7%

Shanghai RAAS Blood Products

Market Cap: CN¥45.2b

Engages in the manufacture and sale of blood products in China.

002252

CN¥6.85

7D

1.3%

1Y

-2.6%

SSY Group

Market Cap: HK$8.6b

An investment holding company, research, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

2005

HK$2.91

7D

0.7%

1Y

-38.5%

Hubei Jumpcan Pharmaceutical

Market Cap: CN¥25.2b

Engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China.

600566

CN¥27.32

7D

2.1%

1Y

-27.0%

CSPC Pharmaceutical Group

Market Cap: HK$74.1b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

1093

HK$6.48

7D

13.5%

1Y

0.6%

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥14.8b

Researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.

600867

CN¥7.64

7D

0.5%

1Y

-20.3%

Beijing Aosaikang Pharmaceutical

Market Cap: CN¥15.8b

Beijing Aosaikang Pharmaceutical Co., Ltd.

002755

CN¥17.03

7D

-1.9%

1Y

62.8%

Dong-E-E-JiaoLtd

Market Cap: CN¥36.2b

Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods.

000423

CN¥56.36

7D

0.7%

1Y

-18.0%

Cosmo Pharmaceuticals

Market Cap: CHF 869.6m

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

COPN

CHF 53.90

7D

3.3%

1Y

-25.9%

Jiang Zhong PharmaceuticalLtd

Market Cap: CN¥14.5b

Engages in the research and development, production, and sale of Chinese patent medicines and health foods in Mainland China.

600750

CN¥23.22

7D

0.4%

1Y

-10.4%

Yantai Dongcheng Pharmaceutical GroupLtd

Market Cap: CN¥11.9b

Engages in the manufacture and sale of biochemical APIs, finished dosage forms, nuclide drugs, and healthy products for cardiovascular, antitumor, urology, orthopedics, and other therapeutic areas.

002675

CN¥14.45

7D

-0.4%

1Y

9.1%

Tibet Cheezheng Tibetan Medicine

Market Cap: CN¥12.9b

Tibet Cheezheng Tibetan Medicine Co., Ltd.

002287

CN¥24.35

7D

-2.2%

1Y

13.6%

Gen Ilac Ve Saglik Urunleri Sanayi Ve Ticaret Anonim Sirketi

Market Cap: ₺41.7b

A pharmaceutical company, manufactures and supplies products to treat rare diseases and disorders worldwide.

GENIL

₺136.20

7D

-0.9%

1Y

118.8%

Page 4 of 14